TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05573724 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05240300 — Predictive Biomarker (PRD): BMX mRNA
Genes: BMX
Study NCT06364852 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05513365 — Predictive Biomarker (PRD): SDC1 mRNA
Genes: SDC1; SDC
Study NCT05513365 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05513365 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SRD5A1 mRNA
Genes: SRD5A1
Study NCT05513365 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SRD5A2 mRNA
Genes: SRD5A2
Study NCT05907603 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05874414 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06514794 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04797767 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06294756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06294756 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06294756 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study NCT06294756 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06294756 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06294756 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT06645665 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05560659 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04875767 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06238934 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06331156 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04860869 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03315299 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT06699836 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT06698965 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT05294484 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT04476901 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05737602 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT06121492 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05455697 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05716113 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05887726 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study NCT05074810 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05968170 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05968170 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06062641 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT05892562 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05179265 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05995262 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05357820 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05470088 — Predictive Biomarker (PRD): TRAPPC9 mRNA
Genes: TRAPPC9; KIAA1882; NIBP; T1
Study NCT05127967 — Predictive Biomarker (PRD): SPG7 mRNA
Genes: SPG7; CAR; CMAR; PGN
Study NCT05769816 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05406739 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT05657938 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06062875 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05523869 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study NCT05309200 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05733559 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05051592 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05051592 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05051592 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04150042 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04150042 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT04150042 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT05320874 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04995588 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study NCT06678269 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06678269 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06678269 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06699693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05717140 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05717140 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05624138 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT06419296 — Predictive Biomarker (PRD): MBL2 mRNA
Genes: MBL2; COLEC1; MBL
Study NCT05516745 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05516745 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT06430021 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT06430021 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05031923 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05031923 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05031923 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06008457 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04856085 — Monitoring Biomarker (MOI): HBV DNA
Study NCT06465550 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05166590 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000852 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06352619 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06275477 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05500170 — Safety Biomarker (SAF): BDNF
Study NCT04243941 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00002095 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06509282 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05527808 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06698861 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03932318 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04688684 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05223569 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05223569 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05223569 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05112549 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05521191 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05604755 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05604755 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT05204602 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05276999 — Predictive Biomarker (PRD): RHD mRNA
Genes: RHD
Study NCT05538572 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06463145 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04604652 — Surrogate Endpoint (SUR): Serum alkaline phosphatase
Study NCT05851014 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05851014 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06298266 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT06298266 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05153070 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05001126 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT04950920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06078696 — Predictive Biomarker (PRD): CD2 mRNA
Genes: CD2; SRBC
Study NCT06691035 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06691035 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06699992 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06699862 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06699524 — Predictive Biomarker (PRD): ADAM17 mRNA
Genes: ADAM17; CSVP; TACE
Study NCT06700057 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00189579 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06657898 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06018077 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06018077 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05027347 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04727294 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05595070 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04760678 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04760678 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06014372 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04660799 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT05957510 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06270524 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05028933 — Predictive Biomarker (PRD): EPCAM mRNA
Genes: EPCAM; GA733-2; M1S2; M4S1; MIC18; TACSTD1; TROP1
Study NCT04913103 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05430555 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06047535 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04806854 — Predictive Biomarker (PRD): LUM mRNA
Genes: LUM; LDC; SLRR2D
Study NCT04990388 — Predictive Biomarker (PRD): AGL mRNA
Genes: AGL; GDE
Study NCT05389618 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03900988 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06699147 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06698484 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06700161 — Safety Biomarker (SAF): Interleukin 1
Study NCT06522438 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05046717 — Predictive Biomarker (PRD): ADAMTS13 mRNA
Genes: ADAMTS13; C9orf8; UNQ6102/PRO20085
Study NCT05328258 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06125587 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04923035 — Predictive Biomarker (PRD): SPN mRNA
Genes: SPN; CD43
Study NCT04929600 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05112913 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06027970 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06027970 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06274203 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05899699 — Predictive Biomarker (PRD): DAP mRNA
Genes: DAP; DAP1
Study NCT03914885 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04817345 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06067776 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06067776 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04824625 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04903080 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05689606 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05689606 — Predictive Biomarker (PRD): CTSB mRNA
Genes: CTSB; CPSB
Study NCT05689606 — Safety Biomarker (SAF): BDNF
Study NCT06148441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06148441 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05559645 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05559645 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05085418 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05085418 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05659394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05396001 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06269068 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT04968509 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04756271 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05973175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05847452 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05847452 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT04671875 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05277285 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT05688605 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06287957 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05069818 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT05900466 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT05900466 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05900466 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT06698757 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05732727 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05732727 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05114993 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05300594 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06300294 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05144854 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05144854 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04864834 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04644887 — Predictive Biomarker (PRD): PNPLA3 mRNA
Genes: PNPLA3; ADPN; C22orf20
Study NCT04759794 — Predictive Biomarker (PRD): MARS1 mRNA
Genes: MARS1; MARS
Study NCT04705051 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05014607 — Predictive Biomarker (PRD): TLR1 mRNA
Genes: TLR1; KIAA0012
Study NCT05514184 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05318963 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05318963 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT05632666 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04705389 — Safety Biomarker (SAF): miR-375
Genes: MIR375
Study NCT06698497 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06698718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06698718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06698718 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06698718 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT06699914 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06699914 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05316259 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT05837806 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06243432 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06243432 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06243432 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04800575 — Surrogate Endpoint (SUR): Bacterial count
Study NCT05785325 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05481346 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06081010 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04799366 — Predictive Biomarker (PRD): CLCN1 mRNA
Genes: CLCN1; CLC1
Study NCT06216704 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05918107 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02850939 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05832593 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study NCT05637905 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study NCT04718285 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT06618976 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06618976 — Predictive Biomarker (PRD): SLC5A1 mRNA
Genes: SLC5A1; NAGT; SGLT1
Study NCT06315868 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06002867 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05589337 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04979793 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05423236 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06196853 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06196853 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT00001004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00001004 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05991518 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05544305 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06428656 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06428656 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06428656 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05751733 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study NCT05751733 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study NCT05479708 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00002086 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04693169 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05716425 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05745779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00120952 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04776499 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04776499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06187727 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06441994 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04878679 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05412745 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04895085 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06306937 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05764057 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05552105 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06474039 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study NCT05672485 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05484336 — Surrogate Endpoint (SUR): Blood pressure